Form 4: Cormorant Sells 60,000 EYPT Shares

Cormorant Asset Management and related entities reported the sale of 60,000 shares of EyePoint, Inc. common stock at a weighted average price of $15.704 per share.

Summary

• Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, and Bihua Chen, identified as former 10% owners, reported a sale of EyePoint, Inc. (EYPT) common stock.
• On December 4, 2025, 60,000 shares of common stock were disposed of.
• The shares were sold at a weighted average price of $15.704 per share, with prices ranging from $15.70 to $15.97.
• Following this transaction, the reporting persons indirectly beneficially own 8,265,000 shares.
• The sale was executed by Cormorant Global Healthcare Master Fund, LP.

Sentiment

Score: 4

Explanation: The sale of shares by a former 10% owner, even if for portfolio rebalancing, generally carries a slightly negative sentiment as it reduces institutional ownership and could signal a lack of conviction, though the amount sold is relatively small compared to their remaining holdings.

Negatives

• A former 10% owner reducing their stake could be perceived negatively by the market, indicating a potential lack of confidence or a strategic portfolio adjustment.
• The sale of 60,000 shares by a significant institutional investor.

Risks

• Potential negative market perception due to a former significant shareholder reducing their stake.
• Increased selling pressure on EyePoint, Inc. stock if the reporting persons continue to divest their remaining 8,265,000 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance from EyePoint, Inc. or the reporting persons regarding the company's future performance.

Management Comments

• The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
• Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.

Industry Context

This Form 4 filing reflects a routine disclosure of an institutional investor's trading activity. Such sales by former significant shareholders are common for portfolio rebalancing or profit-taking and do not necessarily indicate a specific negative outlook on the company's industry position, though they can influence short-term sentiment.

Stakeholder Impact

• Shareholders: May experience short-term negative sentiment or increased selling pressure due to the divestment by a significant institutional investor.

Next Steps

• Monitor future Form 4 filings from Cormorant Asset Management and related entities for further changes in their EyePoint, Inc. holdings.
• Observe EyePoint, Inc.'s stock performance and any subsequent company announcements for potential impacts of this transaction.

Key Dates

Recommendation

While the sale by a former 10% owner is a negative signal, the amount sold (60,000 shares) is relatively small compared to the remaining 8.265 million shares still indirectly held by Cormorant. This could be a routine portfolio adjustment rather than a complete loss of confidence. Investors should hold and monitor future filings and company performance for clearer directional signals.

Keywords

EyePoint Inc, EYPT, Cormorant Asset Management, Insider Trading, Form 4, Stock Sale, Beneficial Ownership, Institutional Investor